Microchip Electrophoresis Assay for TK1 Detection ID: 2014-085
An innovative microchip electrophoresis assay designed for rapid and sensitive detection of the cancer biomarker thymidine kinase-1.
Photo by starlineart - stock.adobe.com
Technology Overview
This technology introduces a microchip electrophoresis immunoaffinity assay for measuring thymidine kinase-1 (TK1) concentration and activity, a significant biomarker in early cancer development. Utilizing a poly(methyl methacrylate) microfluidic device, the assay forms immune complexes with a specific antibody against TK1, allowing for fast, efficient, and precise detection in small sample volumes.
Key Advantages
- High sensitivity and specificity for TK1 detection
- Rapid results, with assay completion in approximately one minute
- Low sample volume requirement, enhancing patient comfort and sample handling efficiency
- Optimized separation of immune complexes using a novel buffer system
- Potential for early cancer detection, improving patient outcomes
Problems Addressed
- Slow and cumbersome traditional methods for TK1 detection
- High sample volume requirements of existing assays
- Limited sensitivity and specificity of current cancer biomarker detection methods
- Delayed detection of cancer, affecting patient prognosis
Market Applications
- Clinical diagnostics for early cancer detection
- Research tools in oncology and biomarker studies
- Development of personalized medicine approaches by monitoring TK1 levels
- Potential use in therapeutic monitoring and efficacy evaluation
Additional Information
Technology ID: 2014-085
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 07 May, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report